Insider Selling: NeueHealth (NYSE:NEUE) Director Sells 3,915 Shares of Stock

NeueHealth, Inc. (NYSE:NEUE) Director Paul Edward Walker sold 3,915 shares of the business’s stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $6.75, for a total value of $26,426.25. Following the transaction, the director owned 488,702 shares in the company, valued at $3,298,738.50. The trade was a 0.79% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

NeueHealth Price Performance

NEUE opened at $6.75 on Tuesday. NeueHealth, Inc. has a 12 month low of $3.79 and a 12 month high of $7.66. The stock has a market capitalization of $60.94 million, a P/E ratio of -0.42 and a beta of 0.59. The business has a 50 day simple moving average of $6.72 and a 200-day simple moving average of $6.73.

NeueHealth (NYSE:NEUE) last released its quarterly earnings data on Thursday, August 7th. The company reported ($1.68) earnings per share (EPS) for the quarter, topping the consensus estimate of ($4.77) by $3.09. The business had revenue of $209.08 million during the quarter, compared to analysts’ expectations of $249.50 million. Research analysts anticipate that NeueHealth, Inc. will post -9.13 EPS for the current year.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in NeueHealth stock. Skandinaviska Enskilda Banken AB publ purchased a new position in shares of NeueHealth, Inc. (NYSE:NEUE) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 29,182 shares of the company’s stock, valued at approximately $201,000. Skandinaviska Enskilda Banken AB publ owned about 0.32% of NeueHealth as of its most recent SEC filing. 63.88% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of NeueHealth in a research note on Saturday, September 27th. One investment analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Reduce” and a consensus price target of $7.00.

About NeueHealth

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.